Dear friends, The COVID-19 crisis is unlike any that we've ever faced as a nation before. It has roiled our economy, killed tens of thousands, and changed the daily lives of every American. If we hope to adequately respond to a crisis as vast and sweeping as this, we must put forth proposals that are as comprehensive as the pandemic they seek to counter. The Heroes Act, which I proudly sponsored, ... Read more »

Dear Friends, As you know, this week, Congress passed H.R. 266, the Paycheck Protection Program and Health Care Enhancement Act, a bill to provide additional funding for small business programs created by the Coronavirus Aid, Relief, and Economic Security (CARES) Act, increase funding for hospitals treating COVID-19 patients, and dramatically increase funding for testing. In the last few weeks, my... Read more »

Washington, D.C.—Today, Congressman Jerrold Nadler (D-NY) delivered the following remarks on the House floor in support of H.R. 266, the Paycheck Protection Program and Health Care Enhancement Act, which expands federal funding for the PPP small business program and provides new funding for hospitals and to expand testing across the country. A copy of Rep. Nadler’s full remarks are below: "In the ... Read more »

Dear Friends, Last month, the $2 trillion Coronavirus Aid, Relief, and Economic Security (CARES) Act was signed into law – the largest aid package in American history, providing substantial relief funding for hospitals and providers responding to COVID-19, as well as support and resources for patients and consumers that have been impacted by the pandemic. In order to further explain the support a... Read more »

Today, Congressman Jerrold Nadler (D-NY) issued a statement condemning the Trump Administration's refusal to lift their ban on fetal tissue research as scientists and medical professionals work tirelessly to develop a COVID-19 vaccine and save lives: "Scientists have told Congress again and again that fetal tissue is the gold standard for vaccine research. The ban on this research imposed by the T... Read more »

Dear Friends, The number of COVID-19, otherwise known as coronavirus, cases reported on American soil grows every day, including six in New York State, and the White House seems ill-prepared to handle the spread of the virus. I was, therefore, proud to join my colleagues in the House in passing a bipartisan emergency spending package that will provide federal and state authorities with the funds ... Read more »

Rep. Nadler Statement on the Trump Administration’s Inadequate Coronavirus Response Faced with the threat of a growing global pandemic, Americans deserve better than a White House totally unprepared and demonstrating no urgency to address coronavirus. Over 80,000 people in 37 countries have been infected with coronavirus and more than 2,500 have already died. Today, the Center for Disease Control ... Read more »

Rep. Nadler Statement on S. 3201, the Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act On Wednesday, I voted against adoption of S. 3201, the Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act, which the Senate passed on January 16. It is absolutely true that the opioid crisis demands serious and appropriate action to ... Read more »

Washington, D.C. —Today, the Committee on Education and Labor advanced the Pregnant Workers Fairness Act (H.R. 2694), a bipartisan proposal introduced by Congressman Jerrold Nadler (D-NY) to secure clear and strong protections for pregnant workers. The legislation guarantees pregnant workers’ right to reasonable accommodations–such as extra bathroom breaks, relief from heavy lifting, and other min... Read more »

Dear Friends, This week, while the House Judiciary Committee continued its work on impeachment, I voted on two major pieces of legislation on the House floor. On Thursday, I voted in support of H.R. 3, the Elijah E. Cummings Lower Drug Prices Now Act. This landmark legislation will, for the first time, allow Medicare to negotiate drug prices directly with drug companies to bring down the cost of ... Read more »